The National Institute for Communicable Diseases (NICD) is the national public health insitute for South Africa. It provides reference microbiology,virology,epidemiology, surveillance and public health research to support the government’s response to communicable disease threats.
The NICD is organised into functional Centres, bringing together expertise in both reference microbiology and epidemiology to enable an intergrated public health response to communicable disease threats.
The NICD primarily supports the programmes of the National and Provincial Departments of Health. As well as national support, the NICD also provides public health services such as collaborating laboratory or regional reference laboratory functions for global programmes of the World Health Organisation (WHO)
The NICD has established co-operatives agreements with partner national public health institutions such as the Center for Disease Control (CDC) and NIH/NIAID of the USA, the European Centre for Disease Control (ECDC) and the Health Protection Agency (HPA) of the United Kingdom, as well as other internationally recognised public health insitutions.
Une fillette de trois ans sous une moustiquaire à Mukuli, dans l'ouest du Kenya. Elle a reçu les quatre doses de RTS,S, le premier vaccin antipaludique au monde.
Yasuyoshi Chiba/AFP via Getty Images
Jaishree Raman, National Institute for Communicable Diseases
Chaque année, 40 millions d'enfants naissent dans des régions d'Afrique touchées par le paludisme. Deux nouveaux vaccins sont des armes importantes dans la lutte contre cette maladie.
A three-year-old girl under a mosquito net in Mukuli, western Kenya. She had received all four doses of RTS,S, the world’s first malaria vaccine.
Yasuyoshi Chiba/AFP via Getty Images
Jaishree Raman, National Institute for Communicable Diseases
Los programas nacionales de control de la malaria en el continente africano han demostrado una gran resiliencia a pesar de los retos económicos y la competencia con otros objetivos sanitarios. En la actualidad, se enfrentan a nuevos desafíos.
Jocelyn Moyes, National Institute for Communicable Diseases; Cheryl Cohen, National Institute for Communicable Diseases, and Sibongile Walaza, University of the Witwatersrand
Flu vaccines remain the most effective method available to prevent flu illness, especially severe illness.
Seorang pekerja kesehatan menyiapkan sebuah vaksin malaria di Yala, Kenya.
Brian Ongoro / AFP via Getty Images
Shüné Oliver, National Institute for Communicable Diseases
Perubahan iklim dapat mempengaruhi distribusi vektor malaria. Kami berfokus secara khusus pada bagaimana vektor yang resisten terhadap insektisida terpengaruh vektor yang rentan terhadap insektisida.
Une usine produisant des moustiquaires imprégnées à Arusha, en Tanzanie.
Photo : Charles Ommanney/Getty Images
Husna Ismail, National Institute for Communicable Diseases and Olga Perovic, National Institute for Communicable Diseases
In hospitals, infection prevention and control cannot be met without a hygienically clean, and safe environment that has an adequate supply of clean running water.
Global climate is changing rapidly. This has a range of public health implications.
CDC/ James Gathany
Shüné Oliver, National Institute for Communicable Diseases and Jaishree Raman, National Institute for Communicable Diseases
As the Earth warms up the malaria vector will develop faster, allowing them to breed faster, bite more frequently and expand into formerly unsuitable habitats.
80% of malaria deaths are in children younger than five.
Olympia de Maismont/AFP via Getty Images
Jaishree Raman, National Institute for Communicable Diseases
For a malaria vaccine to have an impact, health promotion is key. Awareness campaigns must address safety concerns and emphasise expected positive impacts.
Michelle J. Groome, National Institute for Communicable Diseases; Juliet Pulliam, South African Centre for Epidemiological Modelling & Analysis (SACEMA) , and Sheetal Silal, University of Cape Town
Repeated resurgences of SARS-CoV-2 transmission are expected in the years to come.
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases